placeholder image
B. A. Buckingham All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2024
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 
    Endocrine Reviews. 2023
  • Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. 
    Diabetes Technology & Therapeutics. 2023
  • Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial. 
    Diabetes care. 2022
  • First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 
    Diabetes care. 2021
  • Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2017
  • Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. 
    JAMA. 2016
    • Conference Poster
  • Increased HbA1c variability may shorten time to microalbuminuria development in type 1 diabetes (T1D) [poster]
    2018
    • Review
  • Decreasing the burden of carbohydrate counting and meal announcement with automated insulin delivery, meal recognition, and autocorrection doses: a case study [review]. 
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 
    The lancet. Diabetes & endocrinology. 2023
  • Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 
    Diabetes care. 2019
    • Abstract
  • First home evaluation of the Omnipod Horizon automated glucose control system at specific glucose targets in children with type 1 diabetes [abstract]. 
    Diabetes. 2020
    • Contact
    full name
  • B. A. Buckingham
    • Quick Info
     
    Collaboration